Evidence map›Paper›PMID 22038913›Full record

ArticleInfection and immunity2012

LipC (Rv0220) is an immunogenic cell surface esterase of Mycobacterium tuberculosis.

Guomiao Shen, Krishna Singh, Dinesh Chandra, Carole Serveau-Avesque, Damien Maurin, Stéphane Canaan, Rupak Singla, Digambar Behera, Suman Laal

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 46 citations in OpenAlex.

  1. Roles of Lipolytic enzymes inFrontiers in microbiology · 2024
    Review
  2. The cause-effect relation of tuberculosis on incidence of diabetes mellitus.Frontiers in cellular and infection microbiology · 2023
    Review
  3. Article
  4. Infection and immunity · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Far-red fluorogenic probes for esterase and lipase detection.Chembiochem : a European journal of chemical biology · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Guomiao ShenDepartment of Pathology, New York University Langone Medical Center, New York, NY, USA.
Krishna Singh
Dinesh Chandra
Carole Serveau-Avesque
Damien Maurin
Stéphane Canaan
Rupak Singla
Digambar Behera
Suman Laal
NYU Langone Health · USCentre National de la Recherche Scientifique · FRLRS Institute of Tuberculosis and Respiratory Diseases · INAix-Marseille Université · FRVA NY Harbor Healthcare System · US

Funding

TRAINING PROGRAM IN TB AND HIV PREVENTION AND TREATMENTD43TW001409 · FIC · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LAAL, SUMAN · 2000 to 2011
$4.6M
Antibody Based Diagnosis for TBR01AI056257 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LAAL, SUMAN · 2003 to 2007
$2.0M
FIC NIH HHS D43 TW001409FIC NIH HHS TW001409NIAID NIH HHS AI056257NIAID NIH HHS R01 AI056257
6 · The paper itself

Abstract

We have reported previously the identification of novel proteins of Mycobacterium tuberculosis by the immunoscreening of an expression library of M. tuberculosis genomic DNA with sera obtained from M. tuberculosis-infected rabbits at 5 weeks postinfection. In this study, we report the further characterization of one of these antigens, LipC (Rv0220). LipC is annotated as a member of the Lip family based on the presence of the consensus motif "GXSXG" characteristic of esterases. Although predicted to be a cytoplasmic enzyme, we provide evidence that LipC is a cell surface protein that is present in both the cell wall and the capsule of M. tuberculosis. Consistent with this localization, LipC elicits strong humoral immune responses in both HIV-negative (HIV-) and HIV-positive (HIV+) tuberculosis (TB) patients. The absence of anti-LipC antibodies in sera from purified protein derivative-positive (PPD+) healthy subjects confirms its expression only during active M. tuberculosis infection. Epitope mapping of LipC identified 6 immunodominant epitopes, 5 of which map to the exposed surface of the modeled LipC protein. The recombinant LipC (rLipC) protein also elicits proinflammatory cytokine and chemokine responses from macrophages and pulmonary epithelial cells. rLipC can hydrolyze short-chain esters with the carbon chain containing 2 to 10 carbon atoms. Together, these studies demonstrate that LipC is a novel cell surface-associated esterase of M. tuberculosis that is highly immunogenic and elicits both antibodies and cytokines/chemokines.

Indexed as

Amino Acid MotifsAnimalsAntibodies, BacterialBacterial CapsulesCell WallCytokinesEpithelial CellsEpitope MappingEsterasesEstersHIV InfectionsHumansHydrolysisImmunodominant EpitopesMacrophagesMembrane ProteinsAntibodies, BacterialCytokinesEsterasesEstersImmunodominant EpitopesMembrane ProteinsRecombinant Proteins

Identifiers

PMID22038913
PMCPMC3255680
OpenAlexW2066887966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.